Predictive Factors for the Effectiveness of the Ilioinguinal Iliohypogastric Nerve Block for Hernia Surgery
NCT ID: NCT06121726
Last Updated: 2025-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
343 participants
OBSERVATIONAL
2023-10-13
2025-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to evaluate the success of the II-IH nerve block as the preferred anesthesia strategy for patients undergoing unilateral inguinal hernia repair using the Lichtenstein technique. The study will analyze various factors such as BMI, age, optimal ultrasound vision, amount of anesthesia used, dose of anesthesia administered, time between block execution and incision, and sedative dose needed to determine independent variables of block effectiveness.
The study will include patients aged 18 or older, with ASA I-II-III classification, and who provide informed consent. Patients with allergies to local anesthetics, certain medical conditions, obesity, difficulty visualizing target structures, non-cooperative behavior, or taking anticoagulant therapy will be excluded.
The study will be conducted at the Sant'Antonio Hospital (Padova University Hospital) operating rooms for one year, aiming to recruit around 400 patients.
Informed consent for data processing will be obtained during the preoperative anesthesia visit, and standard anesthesia procedures will be followed during the surgery.
As usual care the patient will be monitored before surgery using an electrocardiogram, oxygen saturation measurement, and non-invasive blood pressure. After adequate sedation, the II-IH nerve block will be performed under sterile conditions and ultrasound guidance.
Participation in the study does not modify the commonly used anesthesia procedures and does not pose any additional risks or provide direct benefits to the patients. The data collected will be treated confidentially and used exclusively for the study's purposes.
Data collection will be conducted through a paper-based form, and only a few variables will be recorded. The study's findings will be made public, even if negative, and will be submitted to the ethics committee within twelve months of data collection completion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound-guided Ilioinguinal/Iliohypogastric Nerve Block
NCT05559437
Local Anesthetic Infiltration VS Trasversalis Fascia Block VS Spinal Anesthesia
NCT03128216
Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair
NCT01326039
To Compare Ilioinguinal/Iliohypogastric Block to Wound Infiltration for Pain Relief After Hernia Repair in Adults
NCT04462510
Medial Versus Traditional Approach to US-guided TAP Blocks for Open Inguinal Hernia Repair
NCT01589796
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is not yet established what the success rate of the anesthetic block is, intended as the absence of the need for further infiltration by the surgeon, the administration of opioid drugs, or the need to convert to general anesthesia, nor what the independent risk factors are for the positive outcome of the procedure. The aim of this study is therefore to evaluate the success of the ilioinguinal-iliohypogastric block as the anesthetic strategy of choice in patients undergoing unilateral inguinal hernioplasty with the Lichtenstein technique, and the independent variables of block effectiveness, analyzing various parameters such as BMI, age, optimal ultrasound visualization, volume of anesthetic used, dose of anesthetic administered, time elapsed between the execution of the II-IH block and the incision, and the necessary dose of sedative drugs.
All patients who need to undergo unilateral inguinal hernioplasty according to the Lichtenstein technique, aged ≥ 18 years, American Society of Anesthesiology-Physical Status (ASA-PS) I-II-III, and who give their informed consent to participate in the study will be recruited. Patients with allergies to local anesthetics; heart disease, kidney disease, liver disease, uncompensated central or peripheral neuropathy; history of coagulopathy (risk/benefit ratio to be evaluated); infection at the site of the procedure; obesity (high BMI) or difficulty in visualizing target structures will be excluded. Non-cooperative patients or those taking anticoagulant therapy will also not be included.
This observational, prospective, monocentric study will be conducted in the operating rooms of the Sant'Antonio Hospital (Hospital-University Company of Padova) and will last for one year. An attempt will be made to recruit the largest number of patients within this time frame, and considering the surgical activity at the operating facility, it is estimated that approximately 400 patients will be enrolled.
The patient will be recruited after verifying the inclusion/exclusion criteria. Each patient will be informed about the study and asked for written informed consent for the treatment of personal data at the time of the standard preoperative anesthesiology visit.
The intraoperative management of the patient will be at the discretion of the anesthesiologist in charge of the patient, without making any changes to their conduct.
The patient will be monitored in the preoperative room with electrocardiogram, pulse oximetry, and non-invasive blood pressure. Once the patient is positioned on the operating table, after adequate sedation with Propofol Targeted Controlled Infusion, the locoregional anesthesia, or II-IH nerve block, will be performed using a sterile technique and under ultrasound guidance. At the end of the procedure, Paracetamol 1 g will be administered.
With this study, the commonly used anesthetic procedures are not modified, and therefore participation in this study does not entail any additional risk for the patient and there are no direct benefits associated with it. All the clinical activities foreseen for the study are classified as routine procedures as they would be performed or prescribed to the patient even in the event of refusal to participate in the study.
The project's data collection form (CRF) will be paper-based and few variables are expected to be collected. Following the longitudinal design of the study, the CRF will collect data on patients at the time of the anesthesiology visit, during the execution of the II-IH nerve block, and during the surgical procedure. The collected data will be entered into an Excel file by the experimenter and will be processed for the exclusive purposes related to the completion of this study, made anonymous, and, in this form, aggregated in the project's database, solely for the purpose of carrying out the study itself and achieving the predefined objectives. The data will not be disseminated unless in strictly anonymous and aggregated form.
All statistical analyzes will be performed using R version 3.4.0 (2017-04-21). Results will be considered statistically significant for P values ≤ 0.05.
The study data will be made public even in the case of negative results and will be sent in copy to the ethics committee within twelve months from the conclusion of data collection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ilioinguinal-Iliohypogastric nerve block
Patients will receive Ilioinguinal-Iliohypogastric nerve block as standard of care
Ilioinguinal-Iliohypogastric nerve block
local anesthetic will be administered near ilioinguinal-iliohypogastric nerves under ultrasound guidance. Given the observational nature of the study dose and drugs will be decided by the attending anesthesiologist
Local anesthetic
Given the observational nature of the study dose and drugs will be decided by the attending anesthesiologist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ilioinguinal-Iliohypogastric nerve block
local anesthetic will be administered near ilioinguinal-iliohypogastric nerves under ultrasound guidance. Given the observational nature of the study dose and drugs will be decided by the attending anesthesiologist
Local anesthetic
Given the observational nature of the study dose and drugs will be decided by the attending anesthesiologist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
* Unilateral inguinal hernioplasty program using the Lichtenstein technique
Exclusion Criteria
* Cardiac, renal, hepatic, central or peripheral neuropathies that are not compensated
* Anticoagulant therapy
* History of coagulopathy (evaluate risk/benefit ratio)
* Infection at the surgical site
* Non-cooperative patient
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Padova
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alessandro De Cassai
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Padova
Padua, Veneto, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VALI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.